miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.
about
Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinomaNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismmiRNA and mammalian male germ cellsRadiation survivors: understanding and exploiting the phenotype following fractionated radiation therapymiR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasionRole of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literatureThe lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabThe miR-99 family regulates the DNA damage response through its target SNF2HMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesMIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cellsAcfs: accurate circRNA identification and quantification from RNA-Seq data.Getting personal with prostate cancer: adding new pieces to an incomplete jigsaw puzzle.MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinomaCell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancermiRSeq: a user-friendly standalone toolkit for sequencing quality evaluation and miRNA profiling.A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.MicroRNAs As Biomarkers For Clinical Features Of Lung CancerIdentification and pathway analysis of microRNAs with no previous involvement in breast cancer.Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.An atlas of DNA methylomes in porcine adipose and muscle tissues.Maternal diet-induced microRNAs and mTOR underlie β cell dysfunction in offspring.Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinomaMicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinomaTumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.Characterization of human plasma-derived exosomal RNAs by deep sequencing.MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing.A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreasMicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214MicroRNA Profiling of Laser-Microdissected Hepatocellular Carcinoma Reveals an Oncogenic Phenotype of the Tumor CapsuleIntrinsic features in microRNA transcriptomes link porcine visceral rather than subcutaneous adipose tissues to metabolic riskA genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21.MicroRNA-99 family members suppress Homeobox A1 expression in epithelial cells.MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor developmentPathway analysis of microRNA expression profile during murine osteoclastogenesisMicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.The role of microRNAs in the biology of rare diseases.The miRNA Transcriptome Directly Reflects the Physiological and Biochemical Differences between Red, White, and Intermediate Muscle Fiber Types.
P2860
Q24600829-CAB6CA1C-83BD-4F9F-A45E-4298F9A9E11EQ26774456-A29EEF56-FF48-4DE3-A021-6E880DD9CB87Q26992374-259EEDC3-6645-4AD3-9D7A-168F09F7EEADQ27026696-1CBF3828-0146-4692-BFE2-6E0C0F929253Q27316744-5897F2BE-8437-4B68-9CDF-F796D2F9D1A1Q28071830-AC530489-4462-4A99-B644-120542445565Q30300669-670A17FE-B389-44F7-9C39-AB01F83CE3CCQ30410739-C59AC4C8-4A92-489F-A822-C2E167E2C51BQ30415894-FDE29E2D-2937-4A07-B208-B1D7577D1443Q30417554-F573BE4D-F6A7-4C14-AA33-D57344EE49C0Q30859743-D03969B2-A635-4B16-A4BA-DE35FDC3D3A6Q31047754-C3104C08-4FB8-4E94-B464-A1B4681D6DB2Q31147507-A61618F2-D126-4136-BCDC-24203FA0B1D1Q33351113-E7BDBC8F-E190-42A0-9937-BEDC5781460DQ33555052-33C74BAF-EA18-4AB5-B5C0-28A5DB362653Q33889872-CEAF6315-9579-4B55-8CB8-789C7B3DF9C1Q33993061-C28CF33D-F176-4889-8C7E-1C7826A11033Q34036145-668D9D3D-9DBF-48A7-96CA-23C7C0E56148Q34158964-849C4E12-605F-4661-8938-971E74189B40Q34206037-2AF1FB07-C598-4CED-96CE-42672B3B7874Q34263619-D2F76242-1313-4E2B-8823-23A310504853Q34278419-22F773F0-5697-4774-B6AE-D97146BDB08DQ34311605-ED031609-0DDA-465C-9170-391D94FB05D1Q34393036-DBCBC6B9-C5BD-4BE7-A87D-93197310F586Q34485641-052C7243-36CC-48C1-B3F4-6F4C88A401C6Q34624695-2729A3FB-D6FC-435B-94EE-034BBBA4577DQ34714581-0FD0445B-D668-4A58-804A-DC3A07F44ABEQ34749586-D6BE44E9-02FF-4ABB-8825-61A3E9A4A40AQ34994302-ABF3037B-C421-45CC-99CD-BD7AB3374458Q35027675-9C847056-DD60-407E-A6BE-E3A3A0EE9EEAQ35028814-1319B252-21CA-4F46-B845-0100DA0D23C5Q35040373-441BE879-7329-4811-83EA-ED69F31B659EQ35047821-DCA97FA4-DDA3-4972-AA89-BC7564A2486BQ35061084-D493A15A-70D1-49A4-92A6-FAE57D11438FQ35123077-091F0F2B-ADA3-464F-B59D-E1ED70D0B3E4Q35207545-B064CECF-DDF6-4AD4-9895-E31B69FCCEE4Q35252690-97D0E10B-91C7-45B1-8333-EEA14BF8B4EBQ35378724-F141FC18-9B8E-4F94-B66F-B2FAD431D989Q35536045-36706C3B-3B39-4BAD-9F36-88C04B6FEAB5Q35621803-A2773D8F-0F9C-4D5F-9BB8-B69554795096
P2860
miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
miR-99 family of MicroRNAs sup ...... ate cancer cell proliferation.
@ast
miR-99 family of MicroRNAs sup ...... ate cancer cell proliferation.
@en
type
label
miR-99 family of MicroRNAs sup ...... ate cancer cell proliferation.
@ast
miR-99 family of MicroRNAs sup ...... ate cancer cell proliferation.
@en
prefLabel
miR-99 family of MicroRNAs sup ...... ate cancer cell proliferation.
@ast
miR-99 family of MicroRNAs sup ...... ate cancer cell proliferation.
@en
P2093
P2860
P50
P1433
P1476
miR-99 family of MicroRNAs sup ...... ate cancer cell proliferation.
@en
P2093
Clive Evans
Dandan Sun
Hak Kyun Kim
Mirela Matecic
Roderick V Jensen
Yong Sun Lee
P2860
P304
P356
10.1158/0008-5472.CAN-10-1031
P407
P577
2011-01-06T00:00:00Z